Overall, while xanthinuria type I may lead to hypouricemia, the effects on cardiovascular health remain unclear, and additional studies are warranted to better understand the relationship between XOR activity, purine metabolism, and cardiovascular outcomes. This evidence concerns the gene XDH and xanthinuria type I.